P3 Health Partners Inc. — Form 8-K Summary
Reporting date: August 17, 2022; filed August 19, 2022. The filing concerns Nasdaq listing compliance and delayed SEC periodic reports, not operating or financial results.
Business Context and Reporting Period
P3 Health Partners Inc. is a Delaware company headquartered in Henderson, Nevada. Its Class A common stock and warrants trade on the Nasdaq Global Capital Market under the symbols PIII and PIIIW.
The company reported that its Annual Report on Form 10-K for the year ended December 31, 2021, its Form 10-Q for the quarter ended March 31, 2022, and its Form 10-Q for the quarter ended June 30, 2022 had not been filed as of the date of the notice.
Financial Metrics and Liquidity
The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes and Listing Compliance
- On August 16, 2022, the company filed a Form 12b-25 notifying the SEC that its second-quarter 2022 Form 10-Q would be filed late.
- On August 17, 2022, Nasdaq notified the company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports.
- The company had previously disclosed delays involving its 2021 Form 10-K and first-quarter 2022 Form 10-Q.
- The Nasdaq notice had no immediate effect on the listing or trading of the company’s common stock.
Outlook, Risks, and Unusual Items
- Nasdaq previously granted the company until September 27, 2022 to regain compliance. Any additional Nasdaq staff exception is limited to that date.
- The company must submit an updated compliance plan to Nasdaq by September 1, 2022, describing progress under its existing plan and addressing the delayed second-quarter filing.
- Management stated that it expected to file the 2021 Form 10-K and both 2022 Form 10-Q reports on or before September 27, 2022.
- The principal risk is potential further Nasdaq action if the delinquent filings are not completed by the applicable deadline. The filing does not state that delisting had occurred.
Key Facts for Investor Verification
- Confirm whether the company filed the 2021 Form 10-K and the first- and second-quarter 2022 Form 10-Q reports by September 27, 2022.
- Review any subsequent Nasdaq determination regarding continued listing or additional extensions.
- Assess the financial results, liquidity, debt, internal controls, and any audit or accounting matters disclosed in the delayed periodic reports.
- Review the company’s updated compliance plan and subsequent SEC filings for explanations of the reporting delays.